MedTrace Logo

Effectiveness of Vojta Therapy in Motor Development of Preterm Children

NCT01838278 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2013-05-07

No results posted yet for this study

Summary

\- Justification: Prematurely born children have an increased prevalence of neurodevelopment problems in the first two years. Knowledge regarding the effects of early intervention programs is essential to the follow up of these children and the families.

-Hypothesis: The Vojta Therapy Model showed beneficial effects on motor development outcomes reported by Bayley Sales of Infant Development-Second Edition, in the first 18 months of life on European sample.

Conditions

Interventions

BEHAVIORAL

Vojta Physiotherapy Method

Children in the experimental group or Vojta Group, received two weekly sessions of sensory-motor stimulation and two weekly sessions of Vojta Physiotherapy. Sensory motor stimulation and Vojta physiotherapy sessions lasted 50 minutes each. A guidance programme was also given to parents to carry out at home to promote the overall development of the child and teach the necessary Vojta method exercises, these were to be performed four times a day for 20 minutes.

Sponsors & Collaborators

  • Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

    collaborator OTHER

  • Universidad de Murcia

    lead OTHER

Principal Investigators

  • Julio PL Perez-Lopez, Phd · Universidad de Murcia

  • Francisco FR J. Fernández-Rego, MD · Universidad de Murcia

  • María Isabel CG Casbas-Gómez, MD · Early Intervention Centre "Fina Navarro López" of Lorca City Council. Murcia. Spain

  • María Teresa MF Martínez-Fuentes, Phd · Universidad de Murcia

  • Angela DH Díaz-Herrero, PHd · Universidad de Murcia

  • Alfredo BN G. Brito de la Nuez, Phd · Universidad de Murcia

  • Tatiana Izabele SR Jaworski de Sa Riechi, PHd · Federal University of Parana - Brazil

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Month
Max Age
18 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-03-31
Completion
2014-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01838278 on ClinicalTrials.gov